Skip to main content
VITA LIFE SCIENCES LIMITED.. logo

VITA LIFE SCIENCES LIMITED.. — Investor Relations & Filings

Ticker · VLS ISIN · AU000000VLS8 ASX Manufacturing
Open in API
Filings indexed 1,058 across all filing types
Latest filing 2025-06-16 Transaction in Own Shar…
Country AU Australia
Listing ASX VLS

About VITA LIFE SCIENCES LIMITED..

https://vitalifesciences.com/

Vita Life Sciences Limited is a healthcare company focused on the development, marketing, and distribution of vitamins, minerals, and nutritional supplements. The company operates primarily through its core brands, including VitaHealth and Herbs of Gold, offering a diverse range of health products designed to support general well-being, immunity, and specific health concerns. Its product portfolio encompasses herbal medicines, dietary supplements, and functional foods formulated using evidence-based research and high-quality ingredients. The company maintains a significant presence across the Asia-Pacific region, serving markets in Southeast Asia and Oceania. By leveraging a multi-channel distribution strategy, including pharmacies, health food stores, and online platforms, the company provides accessible health solutions to a broad consumer base.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back of its own shares, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement specifically about the company's share repurchase activity. There are no financial statements or comprehensive financial reports present, only transactional details of the buy-back. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length is over 5,000 characters and contains substantive buy-back data, confirming it is not merely an announcement of a report but the actual notification of the buy-back activity.
2025-06-16 English
Profit Guidance 1 page 144.5KB
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 17 June 2025 from Vita Life Sciences providing financial guidance for the half year ending 30 June 2025. It includes forecasted sales and pre-tax profit figures, comparisons to the prior corresponding period, and commentary on business strategy and market conditions. The document is only 1459 characters long, which is quite brief and does not contain actual financial statements or detailed financial data. It is clearly a forward-looking guidance announcement rather than a full interim or annual report. According to the rules, such brief guidance announcements are best classified as Regulatory Filings (RNS) because they do not contain substantive financial data or full report content. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2025-06-16 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back of its own shares, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement related to the company's share repurchase activity. The document is not a financial report, earnings release, or management discussion, but specifically a notification of transactions in own shares (share repurchase). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and content confirm it is a full notification rather than a brief announcement or report publication notice.
2025-06-04 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement specifically about the company's repurchase of its own shares. This matches the description of 'Transaction in Own Shares' filings, which report on share repurchase activities. The document is about a buy-back update and not a full financial report or other types of filings. Therefore, the correct classification is POS (Transaction in Own Shares). The document length and content support a high confidence in this classification.
2025-06-03 English
AGM Address and Presentation 34 pages 7.7MB
AGM Information Classification · 100% confidence The document is a detailed transcript and presentation material from the 2025 Annual General Meeting (AGM) of Vita Life Sciences Limited. It includes the Chairman's address, Managing Director's presentation, formal business items including resolutions, voting procedures, and Q&A sessions. The content is focused on the AGM event itself, including speeches and presentations made during the meeting, rather than being a standalone annual report or financial statement. The presence of agenda items, resolutions, and shareholder voting confirms this is AGM-related material. Therefore, the document fits the category of AGM Information (AGM-R). The document length and detail also confirm it is not a brief announcement or a report publication notice.
2025-05-21 English
Results of Meeting 2 pages 135.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement dated 22 May 2025, addressed to the Australian Securities Exchange, reporting the results of the Annual General Meeting (AGM) of Vita Life Sciences Ltd. It references compliance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, which relate to disclosure of voting results. The content includes detailed proxy vote counts and outcomes for resolutions such as the remuneration report, director re-election, remuneration payable to non-executive directors, and a share buy-back proposal. The document does not contain financial statements or detailed financial analysis but focuses solely on the voting results of the AGM resolutions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and is a direct announcement of voting outcomes, not a report or presentation material from the AGM itself.
2025-05-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.